Traumaand Extremities — Net Sales
Stryker Traumaand Extremities — Net Sales increased by 0.3% to $1.92B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.1%, from $1.70B to $1.92B. Over 3 years (FY 2021 to FY 2024), Traumaand Extremities — Net Sales shows an upward trend with a 9.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong market adoption of the company's trauma surgical solutions and potential expansion in surgical procedure volumes, while a decrease may signal competitive pressure or a slowdown in elective and trauma-related orthopedic surgeries.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and implants specifically designed f...
Peer comparison
Peers in the medical device sector report similar revenue streams under orthopedic or trauma-specific segments, often benchmarked against total orthopedic market growth rates.
syk_segment_trauma_and_extremities_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.35B | $1.28B | $1.42B | $1.37B | $1.35B | $1.34B | $1.55B | $1.54B | $1.53B | $1.50B | $1.72B | $1.66B | $1.66B | $1.70B | $1.99B | $1.89B | $1.91B | $1.92B |
| QoQ Change | — | -5.2% | +11.3% | -3.7% | -1.3% | -0.6% | +15.2% | -0.6% | -0.4% | -1.8% | +14.4% | -3.5% | +0.2% | +2.0% | +17.3% | -5.1% | +1.3% | +0.3% |
| YoY Change | — | — | — | — | +0.3% | +5.2% | +8.9% | +12.3% | +13.3% | +11.9% | +11.1% | +7.9% | +8.6% | +12.9% | +15.8% | +13.9% | +15.0% | +13.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's traumaand extremities — net sales?
- Stryker (SYK) reported traumaand extremities — net sales of $1.92B in Q3 2025.
- How has Stryker's traumaand extremities — net sales changed year-over-year?
- Stryker's traumaand extremities — net sales increased by 13.1% year-over-year, from $1.70B to $1.92B.
- What is the long-term trend for Stryker's traumaand extremities — net sales?
- Over 3 years (2021 to 2024), Stryker's traumaand extremities — net sales has grown at a 9.6% compound annual growth rate (CAGR), from $5.33B to $7.01B.
- What does traumaand extremities — net sales mean?
- The total revenue earned from selling medical products used to treat bone fractures and extremity-related orthopedic injuries.